LIMN 주가 차트
LIMN 주가 예측
Liminatus Pharma Inc
$0.2
2.16%
$0
종가: Apr 27, 16:00:00 GMT-4
$0.2
2.66%
$0
프리마켓: Apr 28, 09:11:03 GMT-4
뒤로
Liminatus Pharma Inc (LIMN) 주가 예측
주요 통계
이전 종가
$0.1982
시가
$0.2
일일 범위
$0.1978 - $0.2079
52주 범위
$0.1592 - $33.66
거래량
804.2K
평균 거래량
7.8M
배당수익률
--
EPS(TTM)
-0.56
시가총액
$9.3M
LIMN란 무엇인가요?
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company is headquartered in La Palma, California. The company went IPO on 2021-05-18. The firm is engaged in the development of a second generation CD47 blockade antibody designed to prevent the induction of severe anemia and thrombocytopenia observed with first generation CD47 blockades. The Company’s candidate, IBA101, is a humanized anti-CD47 monoclonal antibody. The CD47 checkpoint inhibitor’s initial indication is expected to be patients with advanced solid cancers, including non-small cell lung cancer. IBA101 is a humanized anti-human CD47 monoclonal antibody with a human IgG4 Fc, designed to preferentially bind nucleated cells, such as immune and tumor cells, while sparing anucleate cells like red blood cells and platelets. IBA101 promotes macrophage-mediated phagocytosis of tumor cells.